| Income Statement | 2025-09-30 | 2025-06-30 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|
| Net loss from continuing operations | -24,377 | -10,578 | -8,785 | 7,170 |
| Net (loss) income from discontinued operations | 0 | 0 | -370 | 238 |
| Net loss | -24,377 | -10,578 | -9,155 | 7,408 |
| Net unrealized gain on available-for-sale investments | 294 | 251 | 3,111 | 301 |
| Comprehensive loss | -24,083 | -10,327 | -6,044 | 7,709 |
| Basic weighted average number of class a and class b common shares and common share equivalents outstanding (in shares) | 512,743,521 | 509,043,210 | 490,180,103 | 487,483,087 |
| Diluted weighted average number of class a and class b common shares and common share equivalents outstanding (in shares) | 512,743,521 | 509,043,210 | 490,180,103 | 495,179,955 |
CLOVER HEALTH INVESTMENTS, CORP. DE (CLOV)
CLOVER HEALTH INVESTMENTS, CORP. DE (CLOV)